Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 0 | 0 | 654 |
| Gross Profit | N/A | N/A | 654 |
| Operating Expenses | 105,766 | 68,513 | 61,163 |
| Operating Income | -105,766 | -68,513 | -60,509 |
| Interest Expense | 137 | 205 | 91 |
| Other Income | 7,570 | 2,324 | 1,323 |
| Pre-tax Income | -98,333 | -66,394 | -59,277 |
| Net Income Continuous | -98,333 | -66,394 | -59,277 |
| Net Income | $-98,333 | $-66,394 | $-59,277 |
| EPS Basic Total Ops | -3.09 | -12.40 | -36.36 |
| EPS Basic Continuous Ops | -3.09 | -12.40 | -36.37 |
| EPS Diluted Total Ops | -3.09 | -12.40 | -36.36 |
| EPS Diluted Continuous Ops | -3.09 | -12.40 | -36.37 |
| EPS Diluted Before Non-Recurring Items | -3.09 | -12.40 | -36.36 |
| EBITDA(a) | $-105,462 | $-68,242 | $-60,389 |